Tarlatamab – March 2026 – May 2026

Powder for injection 1 mg, Powder for injection 10 mg

Brand names:
- Imdelltra®
Pharmaceutical Company:
- AMGEN AUSTRALIA PTY LIMITED
Condition/Indication: Extensive-stage small cell lung cancer with progression on or after platinum-based chemotherapy
Meeting Date: March 2026

Public Summary Documents

Related Public Summary Documents

Last updated

24 April 2026